Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118915 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Actual shortage | 2025-04-04 | 2025-04-24 | 254130 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-05-23 | 2017-09-19 | 10889 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-08-03 | 2023-10-04 | 200910 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-19 | 126921 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2018-03-16 | 2018-07-30 | 43152 |
| TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2024-08-08 | 2024-09-12 | 234879 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-06 | 2020-11-12 | 128037 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2020-09-03 | 2020-10-01 | 123729 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155174 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2022-08-18 | 2022-09-08 | 167241 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128007 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 199053 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2022-01-27 | 2022-02-05 | 153715 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-27 | 2021-02-11 | 129045 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-07-27 | 2023-10-12 | 200240 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-06-26 | 2023-07-06 | 196427 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2018-03-13 | 2018-07-30 | 42588 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2024-11-08 | 2025-01-09 | 242352 |
| TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2020-04-02 | 2020-05-01 | 110694 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Discontinued | 2025-10-22 | 2025-10-22 | 257579 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 |